organization · Reporting owner
Advent Partners GPE VII 2014 Limited Partnership
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ATI Physical Therapy, Inc.ATIP · Entity 79823 | 10% owner | June 16, 2021 | June 28, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ATI Physical Therapy, Inc.
Report date June 16, 2021 · Filed June 28, 2021
Jointly reported with ADVENT INTERNATIONAL, L.P., Advent International GPE VII-A Limited Partnership, Advent International GPE VII-E Limited Partnership, Advent International GPE VII-H Limited Partnership, GPE VII GP Limited Partnership, Advent Partners GPE VII 2014 Cayman Limited Partnership, Advent Partners GPE VII-A 2014 Limited Partnership, Advent Partners GPE VII-A 2014 Cayman Limited Partnership, Advent Partners GPE VII Cayman Limited Partnership
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | IndirectSee Footnotes | 130,300,000 |
Reported balance
Holding disclosure · report date 2021-06-16 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 130,300,000 F1: See Exhibit 99.1 for text of footnote (1) F2: See Exhibit 99.1 for text of footnote (2) F4: See Exhibit 99.1 for text of footnote (4) |
| Earnout SharesSEC Table II · derivative / convertible security | IndirectSee notes | Not disclosed |
Reported balance
Holding disclosure · report date 2021-06-16 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F3: See Exhibit 99.1 for text of footnote (3) F2: See Exhibit 99.1 for text of footnote (2) F4: See Exhibit 99.1 for text of footnote (4) |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1)
F2: See Exhibit 99.1 for text of footnote (2)
F3: See Exhibit 99.1 for text of footnote (3)
F4: See Exhibit 99.1 for text of footnote (4)
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Syneos Health, Inc.
Report date June 07, 2021 · Filed June 09, 2021
Jointly reported with ADVENT INTERNATIONAL, L.P., Advent Partners GPE VII Limited Partnership, Advent Partners GPE VII-A 2014 Limited Partnership, Advent Partners GPE VII Cayman Limited Partnership, Advent Partners GPE VII 2014 Cayman Limited Partnership, Advent Partners GPE VII-A Cayman Limited Partnership, Advent Partners GPE VII-B Cayman Limited Partnership, Advent Partners GPE VII-A 2014 Cayman Limited Partnership
Section 16 reporting ended · disclosed 2021-06-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Notes | 273,821 |
Reported balance
After 2021-06-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-06-07 · Sale · Disposed 6,033,668 · Balance 273,821 F1: See Exhibit 99.1 for text of footnote (1). F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Notes | 0 |
Reported balance
After 2021-06-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-06-07 · Sale · Disposed 273,821 · Balance 0 F3: See Exhibit 99.1 for text of footnote (3). F2: See Exhibit 99.1 for text of footnote (2). F4: See Exhibit 99.1 for text of footnote (4). F5: See Exhibit 99.1 for text of footnote (5). |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1 for text of footnote (1).
F2: See Exhibit 99.1 for text of footnote (2).
F3: See Exhibit 99.1 for text of footnote (3).
F4: See Exhibit 99.1 for text of footnote (4).
F5: See Exhibit 99.1 for text of footnote (5).
lululemon athletica inc.
Report date June 07, 2018 · Filed June 12, 2018
Jointly reported with ADVENT INTERNATIONAL, L.P., Advent Partners GPE VII 2014 Cayman Limited Partnership, Advent Partners GPE VII-A 2014 Limited Partnership, Advent Partners GPE VII-A 2014 Cayman Limited Partnership, Advent International GPE VII Limited Partnership, Advent International GPE VII-B Limited Partnership, Advent International GPE VII-C Limited Partnership, Advent International GPE VII-D Limited Partnership, Advent International GPE VII-F Limited Partnership
Section 16 reporting ended · disclosed 2018-06-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Notes | 10,105,279 |
Reported balance
After 2018-06-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-06-07 · Sale · Disposed 10,000,000 · Balance 10,105,279 F1: Represents shares of Common Stock held directly and sold by: (a) Advent Puma Acquisition Limited ("APAL") (9,703,920 shares); and each of the following entities (a "Specified Advent Fund") - Advent Partners GPE VII-A Limited Partnership (10,651 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,640 shares); Advent Partners GPE VII-B Cayman Limited Partnership (105,751 shares); Advent Partners GPE VII 2014 Limited Partnership (6,120 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,400 shares); Advent Partners GPE VII-A 2014 Limited Partnership (16,851 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,270 shares); Advent Partners GPE VII Limited Partnership (4,451 shares); and Advent Partners GPE VII Cayman Limited Partnership (96,946 shares). F2: Following the reported transaction, the shares of Common Stock were directly owned by: APAL (9,806,083 shares); Advent Partners GPE VII-A Limited Partnership (10,761 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,910 shares); Advent Partners GPE VII-B Cayman Limited Partnership (106,862 shares); Advent Partners GPE VII 2014 Limited Partnership (6,184 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,583 shares); Advent Partners GPE VII-A 2014 Limited Partnership (17,026 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,399 shares); Advent Partners GPE VII Limited Partnership (4,496 shares); and Advent Partners GPE VII Cayman Limited Partnership (97,975 shares). The owners of APAL are the Advent Funds (as defined below) other than than the Specified Advent Funds. F3: APAL, together with Advent International Corporation ("AIC") and the Advent Funds are referred to herein as the "Reporting Persons." The shares directly owned by APAL or by any Specified Advent Fund may be deemed indirectly owned by other Reporting Persons; however, each Reporting Person disclaims beneficial ownership of these securities except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F4: AIC is the Manager of Advent International GPE VII, LLC ("AIGPE VII LLC") which in turn is the General Partner of the following entities (together with AIGPE VII LLC, the "Advent VII Funds"): Advent Partners GPE VII Limited Partnership; Advent Partners GPE VII Cayman Limited Partnership; Advent Partners GPE VII-A Limited Partnership; Advent Partners GPE VII-A Cayman Limited Partnership; Advent Partners GPE VII-B Cayman Limited Partnership; Advent Partners GPE VII 2014 Limited Partnership; Advent Partners GPE VII 2014 Cayman Limited Partnership; Advent Partners GPE VII-A 2014 Limited Partnership; Advent Partners GPE VII-A 2014 Cayman Limited Partnership; GPE VII GP (Delaware) Limited Partnership ("GPEVII GP (Del)"); and GPE VII GP Limited Partnership ("GPEVII GP"). F5: GPEVII GP (Del) is the General Partner of the following entities (together, the "Advent Del Funds"): Advent International GPE VII Limited Partnership; Advent International GPE VII-B Limited Partnership; Advent International GPE VII-C Limited Partnership; Advent International GPE VII-D Limited Partnership; Advent International GPE VII-F Limited Partnership; and Advent International GPE VII-G Limited Partnership. GPEVII GP is the General Partner of the following entities (the "GPE VII GP Funds" and together with the Advent VII Funds and the Advent Del Funds, the "Advent Funds"): Advent International GPE VII-A Limited Partnership; Advent International GPE VII-E Limited Partnership; and Advent International GPE VII-H Limited Partnership. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock held directly and sold by: (a) Advent Puma Acquisition Limited ("APAL") (9,703,920 shares); and each of the following entities (a "Specified Advent Fund") - Advent Partners GPE VII-A Limited Partnership (10,651 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,640 shares); Advent Partners GPE VII-B Cayman Limited Partnership (105,751 shares); Advent Partners GPE VII 2014 Limited Partnership (6,120 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,400 shares); Advent Partners GPE VII-A 2014 Limited Partnership (16,851 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,270 shares); Advent Partners GPE VII Limited Partnership (4,451 shares); and Advent Partners GPE VII Cayman Limited Partnership (96,946 shares).
F2: Following the reported transaction, the shares of Common Stock were directly owned by: APAL (9,806,083 shares); Advent Partners GPE VII-A Limited Partnership (10,761 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,910 shares); Advent Partners GPE VII-B Cayman Limited Partnership (106,862 shares); Advent Partners GPE VII 2014 Limited Partnership (6,184 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,583 shares); Advent Partners GPE VII-A 2014 Limited Partnership (17,026 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,399 shares); Advent Partners GPE VII Limited Partnership (4,496 shares); and Advent Partners GPE VII Cayman Limited Partnership (97,975 shares). The owners of APAL are the Advent Funds (as defined below) other than than the Specified Advent Funds.
F3: APAL, together with Advent International Corporation ("AIC") and the Advent Funds are referred to herein as the "Reporting Persons." The shares directly owned by APAL or by any Specified Advent Fund may be deemed indirectly owned by other Reporting Persons; however, each Reporting Person disclaims beneficial ownership of these securities except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4: AIC is the Manager of Advent International GPE VII, LLC ("AIGPE VII LLC") which in turn is the General Partner of the following entities (together with AIGPE VII LLC, the "Advent VII Funds"): Advent Partners GPE VII Limited Partnership; Advent Partners GPE VII Cayman Limited Partnership; Advent Partners GPE VII-A Limited Partnership; Advent Partners GPE VII-A Cayman Limited Partnership; Advent Partners GPE VII-B Cayman Limited Partnership; Advent Partners GPE VII 2014 Limited Partnership; Advent Partners GPE VII 2014 Cayman Limited Partnership; Advent Partners GPE VII-A 2014 Limited Partnership; Advent Partners GPE VII-A 2014 Cayman Limited Partnership; GPE VII GP (Delaware) Limited Partnership ("GPEVII GP (Del)"); and GPE VII GP Limited Partnership ("GPEVII GP").
F5: GPEVII GP (Del) is the General Partner of the following entities (together, the "Advent Del Funds"): Advent International GPE VII Limited Partnership; Advent International GPE VII-B Limited Partnership; Advent International GPE VII-C Limited Partnership; Advent International GPE VII-D Limited Partnership; Advent International GPE VII-F Limited Partnership; and Advent International GPE VII-G Limited Partnership. GPEVII GP is the General Partner of the following entities (the "GPE VII GP Funds" and together with the Advent VII Funds and the Advent Del Funds, the "Advent Funds"): Advent International GPE VII-A Limited Partnership; Advent International GPE VII-E Limited Partnership; and Advent International GPE VII-H Limited Partnership.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2021 Filed Jun 9, 2021 21:39 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 273,821 | $81.20 | $22,234,265.20 |
DisclosureSEC source: 0001140361-21-020404 · form4.xml · nonDerivative · entry 2 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 0 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 21:39 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 6,033,668 | $81.20 | $489,933,841.60 |
DisclosureSEC source: 0001140361-21-020404 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 273,821 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| May 14, 2021 Filed May 19, 2021 00:15 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 448,942 | $81.04 | $36,382,259.68 |
DisclosureSEC source: 0001140361-21-017941 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,307,489 F1 · kind: See Exhibit 99.1 for text of footnote (1). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| May 06, 2021 Filed May 11, 2021 01:47 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 216,666 | $81.04 | $17,558,612.64 |
DisclosureSEC source: 0001140361-21-016734 · form4.xml · nonDerivative · entry 2 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,756,431 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| May 06, 2021 Filed May 11, 2021 01:47 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,791,652 | $81.04 | $307,275,478.08 |
DisclosureSEC source: 0001140361-21-016734 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 6,973,097 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 00:12 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 322,824 | $74.18 | $23,945,470.20 |
DisclosureSEC source: 0001140361-21-007543 · form4.xml · nonDerivative · entry 2 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 10,764,749 F3 · kind: See Exhibit 99.1 for text of footnote (3). F2 · shares: See Exhibit 99.1 for text of footnote (2). F3 · balance_after: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 00:12 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 4,331,222 | $74.18 | $321,268,391.85 |
DisclosureSEC source: 0001140361-21-007543 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 11,087,573 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). F5 · ownership.nature: See Exhibit 99.1 for text of footnote (5). Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 22:13 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,228,241 | $61.28 | $197,826,608.48 |
DisclosureSEC source: 0001140361-20-027527 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VIII-B Cayman Limited Partnership · CIK 0001677005 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 15,418,795 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document |
| September 17, 2020 Filed Sep 22, 2020 01:55 UTC | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,766,281 | $59.26 | $223,189,812.06 |
DisclosureSEC source: 0001140361-20-021064 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,647,036 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document |
| September 17, 2020 Filed Sep 22, 2020 20:37 UTC Amendment | Syneos Health, Inc. SYNH · Entity 109360 | SaleClass A Common Stock | 3,766,281 | $59.26 | $223,189,812.06 |
DisclosureSEC source: 0001140361-20-021163 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII Limited Partnership · CIK 0001556190 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII Cayman Limited Partnership · CIK 0001561808 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-B Cayman Limited Partnership · CIK 0001563878 · 10% owner Advent Partners GPE VII-A Cayman Limited Partnership · CIK 0001559260 · 10% owner Advent Partners GPE VII-A Limited Partnership · CIK 0001559259 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 18,647,036 F1 · kind: See Exhibit 99.1 for text of footnote (1). F1 · shares: See Exhibit 99.1 for text of footnote (1). F2 · balance_after: See Exhibit 99.1 for text of footnote (2). F3 · ownership.nature: See Exhibit 99.1 for text of footnote (3). F4 · ownership.nature: See Exhibit 99.1 for text of footnote (4). Read SEC document |
| June 07, 2018 Filed Jun 12, 2018 01:46 UTC | lululemon athletica inc. LULU · Entity 3399 | SaleCommon Stock | 10,000,000 | $121.00 | $1,210,000,000.00 |
DisclosureSEC source: 0001140361-18-028158 · form4.xml · nonDerivative · entry 1 ADVENT INTERNATIONAL CORP/MA · CIK 0001034196 · 10% owner Advent Partners GPE VII 2014 Limited Partnership · CIK 0001616578 · 10% owner Advent Partners GPE VII 2014 Cayman Limited Partnership · CIK 0001616563 · 10% owner Advent Partners GPE VII-A 2014 Limited Partnership · CIK 0001616577 · 10% owner Advent Partners GPE VII-A 2014 Cayman Limited Partnership · CIK 0001616564 · 10% owner Advent International GPE VII Limited Partnership · CIK 0001551274 · 10% owner Advent International GPE VII-B Limited Partnership · CIK 0001551276 · 10% owner Advent International GPE VII-C Limited Partnership · CIK 0001551366 · 10% owner Advent International GPE VII-D Limited Partnership · CIK 0001551365 · 10% owner Advent International GPE VII-F Limited Partnership · CIK 0001551363 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Notes Disclosed balance after: 10,105,279 F1 · kind: Represents shares of Common Stock held directly and sold by: (a) Advent Puma Acquisition Limited ("APAL") (9,703,920 shares); and each of the following entities (a "Specified Advent Fund") - Advent Partners GPE VII-A Limited Partnership (10,651 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,640 shares); Advent Partners GPE VII-B Cayman Limited Partnership (105,751 shares); Advent Partners GPE VII 2014 Limited Partnership (6,120 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,400 shares); Advent Partners GPE VII-A 2014 Limited Partnership (16,851 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,270 shares); Advent Partners GPE VII Limited Partnership (4,451 shares); and Advent Partners GPE VII Cayman Limited Partnership (96,946 shares). F1 · shares: Represents shares of Common Stock held directly and sold by: (a) Advent Puma Acquisition Limited ("APAL") (9,703,920 shares); and each of the following entities (a "Specified Advent Fund") - Advent Partners GPE VII-A Limited Partnership (10,651 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,640 shares); Advent Partners GPE VII-B Cayman Limited Partnership (105,751 shares); Advent Partners GPE VII 2014 Limited Partnership (6,120 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,400 shares); Advent Partners GPE VII-A 2014 Limited Partnership (16,851 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,270 shares); Advent Partners GPE VII Limited Partnership (4,451 shares); and Advent Partners GPE VII Cayman Limited Partnership (96,946 shares). F1 · balance_after: Represents shares of Common Stock held directly and sold by: (a) Advent Puma Acquisition Limited ("APAL") (9,703,920 shares); and each of the following entities (a "Specified Advent Fund") - Advent Partners GPE VII-A Limited Partnership (10,651 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,640 shares); Advent Partners GPE VII-B Cayman Limited Partnership (105,751 shares); Advent Partners GPE VII 2014 Limited Partnership (6,120 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,400 shares); Advent Partners GPE VII-A 2014 Limited Partnership (16,851 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,270 shares); Advent Partners GPE VII Limited Partnership (4,451 shares); and Advent Partners GPE VII Cayman Limited Partnership (96,946 shares). F2 · balance_after: Following the reported transaction, the shares of Common Stock were directly owned by: APAL (9,806,083 shares); Advent Partners GPE VII-A Limited Partnership (10,761 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,910 shares); Advent Partners GPE VII-B Cayman Limited Partnership (106,862 shares); Advent Partners GPE VII 2014 Limited Partnership (6,184 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,583 shares); Advent Partners GPE VII-A 2014 Limited Partnership (17,026 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,399 shares); Advent Partners GPE VII Limited Partnership (4,496 shares); and Advent Partners GPE VII Cayman Limited Partnership (97,975 shares). The owners of APAL are the Advent Funds (as defined below) other than than the Specified Advent Funds. F3 · balance_after: APAL, together with Advent International Corporation ("AIC") and the Advent Funds are referred to herein as the "Reporting Persons." The shares directly owned by APAL or by any Specified Advent Fund may be deemed indirectly owned by other Reporting Persons; however, each Reporting Person disclaims beneficial ownership of these securities except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F4 · balance_after: AIC is the Manager of Advent International GPE VII, LLC ("AIGPE VII LLC") which in turn is the General Partner of the following entities (together with AIGPE VII LLC, the "Advent VII Funds"): Advent Partners GPE VII Limited Partnership; Advent Partners GPE VII Cayman Limited Partnership; Advent Partners GPE VII-A Limited Partnership; Advent Partners GPE VII-A Cayman Limited Partnership; Advent Partners GPE VII-B Cayman Limited Partnership; Advent Partners GPE VII 2014 Limited Partnership; Advent Partners GPE VII 2014 Cayman Limited Partnership; Advent Partners GPE VII-A 2014 Limited Partnership; Advent Partners GPE VII-A 2014 Cayman Limited Partnership; GPE VII GP (Delaware) Limited Partnership ("GPEVII GP (Del)"); and GPE VII GP Limited Partnership ("GPEVII GP"). F5 · balance_after: GPEVII GP (Del) is the General Partner of the following entities (together, the "Advent Del Funds"): Advent International GPE VII Limited Partnership; Advent International GPE VII-B Limited Partnership; Advent International GPE VII-C Limited Partnership; Advent International GPE VII-D Limited Partnership; Advent International GPE VII-F Limited Partnership; and Advent International GPE VII-G Limited Partnership. GPEVII GP is the General Partner of the following entities (the "GPE VII GP Funds" and together with the Advent VII Funds and the Advent Del Funds, the "Advent Funds"): Advent International GPE VII-A Limited Partnership; Advent International GPE VII-E Limited Partnership; and Advent International GPE VII-H Limited Partnership. F1 · ownership.direct: Represents shares of Common Stock held directly and sold by: (a) Advent Puma Acquisition Limited ("APAL") (9,703,920 shares); and each of the following entities (a "Specified Advent Fund") - Advent Partners GPE VII-A Limited Partnership (10,651 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,640 shares); Advent Partners GPE VII-B Cayman Limited Partnership (105,751 shares); Advent Partners GPE VII 2014 Limited Partnership (6,120 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,400 shares); Advent Partners GPE VII-A 2014 Limited Partnership (16,851 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,270 shares); Advent Partners GPE VII Limited Partnership (4,451 shares); and Advent Partners GPE VII Cayman Limited Partnership (96,946 shares). F2 · ownership.direct: Following the reported transaction, the shares of Common Stock were directly owned by: APAL (9,806,083 shares); Advent Partners GPE VII-A Limited Partnership (10,761 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,910 shares); Advent Partners GPE VII-B Cayman Limited Partnership (106,862 shares); Advent Partners GPE VII 2014 Limited Partnership (6,184 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,583 shares); Advent Partners GPE VII-A 2014 Limited Partnership (17,026 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,399 shares); Advent Partners GPE VII Limited Partnership (4,496 shares); and Advent Partners GPE VII Cayman Limited Partnership (97,975 shares). The owners of APAL are the Advent Funds (as defined below) other than than the Specified Advent Funds. F3 · ownership.direct: APAL, together with Advent International Corporation ("AIC") and the Advent Funds are referred to herein as the "Reporting Persons." The shares directly owned by APAL or by any Specified Advent Fund may be deemed indirectly owned by other Reporting Persons; however, each Reporting Person disclaims beneficial ownership of these securities except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F4 · ownership.direct: AIC is the Manager of Advent International GPE VII, LLC ("AIGPE VII LLC") which in turn is the General Partner of the following entities (together with AIGPE VII LLC, the "Advent VII Funds"): Advent Partners GPE VII Limited Partnership; Advent Partners GPE VII Cayman Limited Partnership; Advent Partners GPE VII-A Limited Partnership; Advent Partners GPE VII-A Cayman Limited Partnership; Advent Partners GPE VII-B Cayman Limited Partnership; Advent Partners GPE VII 2014 Limited Partnership; Advent Partners GPE VII 2014 Cayman Limited Partnership; Advent Partners GPE VII-A 2014 Limited Partnership; Advent Partners GPE VII-A 2014 Cayman Limited Partnership; GPE VII GP (Delaware) Limited Partnership ("GPEVII GP (Del)"); and GPE VII GP Limited Partnership ("GPEVII GP"). F5 · ownership.direct: GPEVII GP (Del) is the General Partner of the following entities (together, the "Advent Del Funds"): Advent International GPE VII Limited Partnership; Advent International GPE VII-B Limited Partnership; Advent International GPE VII-C Limited Partnership; Advent International GPE VII-D Limited Partnership; Advent International GPE VII-F Limited Partnership; and Advent International GPE VII-G Limited Partnership. GPEVII GP is the General Partner of the following entities (the "GPE VII GP Funds" and together with the Advent VII Funds and the Advent Del Funds, the "Advent Funds"): Advent International GPE VII-A Limited Partnership; Advent International GPE VII-E Limited Partnership; and Advent International GPE VII-H Limited Partnership. F1 · ownership.nature: Represents shares of Common Stock held directly and sold by: (a) Advent Puma Acquisition Limited ("APAL") (9,703,920 shares); and each of the following entities (a "Specified Advent Fund") - Advent Partners GPE VII-A Limited Partnership (10,651 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,640 shares); Advent Partners GPE VII-B Cayman Limited Partnership (105,751 shares); Advent Partners GPE VII 2014 Limited Partnership (6,120 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,400 shares); Advent Partners GPE VII-A 2014 Limited Partnership (16,851 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,270 shares); Advent Partners GPE VII Limited Partnership (4,451 shares); and Advent Partners GPE VII Cayman Limited Partnership (96,946 shares). F2 · ownership.nature: Following the reported transaction, the shares of Common Stock were directly owned by: APAL (9,806,083 shares); Advent Partners GPE VII-A Limited Partnership (10,761 shares); Advent Partners GPE VII-A Cayman Limited Partnership (25,910 shares); Advent Partners GPE VII-B Cayman Limited Partnership (106,862 shares); Advent Partners GPE VII 2014 Limited Partnership (6,184 shares); Advent Partners GPE VII 2014 Cayman Limited Partnership (17,583 shares); Advent Partners GPE VII-A 2014 Limited Partnership (17,026 shares); Advent Partners GPE VII-A 2014 Cayman Limited Partnership (12,399 shares); Advent Partners GPE VII Limited Partnership (4,496 shares); and Advent Partners GPE VII Cayman Limited Partnership (97,975 shares). The owners of APAL are the Advent Funds (as defined below) other than than the Specified Advent Funds. F3 · ownership.nature: APAL, together with Advent International Corporation ("AIC") and the Advent Funds are referred to herein as the "Reporting Persons." The shares directly owned by APAL or by any Specified Advent Fund may be deemed indirectly owned by other Reporting Persons; however, each Reporting Person disclaims beneficial ownership of these securities except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. F4 · ownership.nature: AIC is the Manager of Advent International GPE VII, LLC ("AIGPE VII LLC") which in turn is the General Partner of the following entities (together with AIGPE VII LLC, the "Advent VII Funds"): Advent Partners GPE VII Limited Partnership; Advent Partners GPE VII Cayman Limited Partnership; Advent Partners GPE VII-A Limited Partnership; Advent Partners GPE VII-A Cayman Limited Partnership; Advent Partners GPE VII-B Cayman Limited Partnership; Advent Partners GPE VII 2014 Limited Partnership; Advent Partners GPE VII 2014 Cayman Limited Partnership; Advent Partners GPE VII-A 2014 Limited Partnership; Advent Partners GPE VII-A 2014 Cayman Limited Partnership; GPE VII GP (Delaware) Limited Partnership ("GPEVII GP (Del)"); and GPE VII GP Limited Partnership ("GPEVII GP"). F5 · ownership.nature: GPEVII GP (Del) is the General Partner of the following entities (together, the "Advent Del Funds"): Advent International GPE VII Limited Partnership; Advent International GPE VII-B Limited Partnership; Advent International GPE VII-C Limited Partnership; Advent International GPE VII-D Limited Partnership; Advent International GPE VII-F Limited Partnership; and Advent International GPE VII-G Limited Partnership. GPEVII GP is the General Partner of the following entities (the "GPE VII GP Funds" and together with the Advent VII Funds and the Advent Del Funds, the "Advent Funds"): Advent International GPE VII-A Limited Partnership; Advent International GPE VII-E Limited Partnership; and Advent International GPE VII-H Limited Partnership. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.